Lissun Raises ₹48 Cr for AI Child Development Expansion

Lissun, a specialized health-tech firm dedicated to pediatric developmental care, has successfully closed a Series A funding round, securing INR 48 Crores. The significant capital infusion was spearheaded by Colossa Ventures, signaling strong investor confidence in Lissun's innovative approach to addressing the growing need for specialized child development services in India.

The funding round saw robust participation from a consortium of prominent investors, including Physis Capital, alongside existing backers such as RPSG Capital Ventures, Ivycap Ventures, Rainmatter, Multiply Ventures, and SucSEED Ventures. New strategic partners, New Age India Fund and Beyond Capital Ventures, also joined the round, underscoring the broad appeal and potential of Lissun's mission.

Lissun operates its child care services under the brand Sunshine by LISSUN, which is rapidly expanding its network of child development centers across India. Crucially, the company integrates proprietary AI-driven platforms and tools to enhance therapeutic delivery and accessibility. This fresh capital will fuel the expansion of Sunshine by LISSUN centers into key metropolitan areas, accelerate the development of advanced AI solutions leveraging Lissun's unique data sets, and fortify its clinical processes to ensure consistent, high-quality care.

Krishna Veer Singh, Co-founder and CEO of Lissun, emphasized the pivotal role of technology in the company's vision. "Our AI tools currently empower therapists and parents, but the true potential lies in building AI-led solutions on our own technology and data," Singh stated. "This will enable us to reach millions of children across India who currently lack access to quality developmental care. This funding allows us to scale both our physical centers and our digital platform to serve a significantly larger population of children and families." The Indian market for child developmental and behavioral care is experiencing a critical demand-supply gap, with high-quality, consistent services remaining scarce and fragmented.

The Sunshine by LISSUN brand has demonstrated impressive traction, growing fourfold in the past year. It currently facilitates over 10,000 monthly therapy sessions across its 25 centers and is on track to establish 50 physical locations within the next year. Concurrently, its digital offerings are projected to reach over one million children in the coming years, aiming to democratize access to affordable and effective developmental care. This expansion is critical in a market where early identification of developmental delays is often missed due to lifestyle changes and increased screen time, as noted by Physis Capital's General Partner, Vinay Bansal.

Colossa Ventures founder Vandana Rajadhyaksha highlighted Lissun's impactful model: "One in eight children today is affected by neurodevelopmental disorders, yet access to quality, consistent care remains out of reach for most families. Lissun's model changes that." She further elaborated on how Lissun's integration of home-based therapy and AI-enabled clinical support breaks traditional constraints, enabling broader reach without compromising outcomes. The continued investment from existing partners like RPSG Capital Ventures, who led Lissun's Pre-Series A round, further validates the company's operational excellence and strategic growth trajectory, as confirmed by Sambit Dash, Partner at RPSG Capital Ventures.

Lissun's strategic focus remains on cultivating India's premier single-speciality care ecosystem for children with special needs. This ecosystem is built upon the expanding network of Sunshine by LISSUN centers, a team of highly skilled therapists, and sophisticated AI-led platforms. These platforms, developed using Lissun's proprietary technology and data, are designed to extend the reach of quality care far beyond the physical confines of its centers, addressing a critical unmet need in the Indian healthcare sector.